NLM Logo

Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination MeSH Descriptor Data 2022


MeSH Heading
Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
Tree Number(s)
D02.078.370.141.450.500
D03.383.129.799.725.500
D03.383.679.875.500
D26.310.750
Unique ID
D000068899
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068899
Scope Note
A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.
Entry Term(s)
Janumet
Sitagliptin Phosphate Metformin Hydrochloride Drug Combination
Sitagliptin Phosphate-Metformin Hydrochloride Drug Combination
Registry Number
0
Public MeSH Note
2016; SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE DRUG COMBINATION was indexed under METFORMIN and PYRAZINES 2008-2015
History Note
2016 (2008)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2016/05/31
Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination Preferred
Janumet Narrower
page delivered in 0.174s